Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.

2020 
Interest is growing in the role of pituitary adenylate cyclase-activating polypeptide (PACAP) and its specific PAC1 receptor in migraine and in their antagonism as a strategy for migraine preventio...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    70
    References
    7
    Citations
    NaN
    KQI
    []